A global leader in growth factor medicine

Unlocking one of nature’s most powerful healing proteins with evidence-based scientific innovation

Harnessing the power of PDGF

Lynch Regenerative Medicine (LRM) has been at the forefront of PDGF research and medicine for decades, harnessing its clinical benefits to develop multiple breakthrough wound-healing medications and skincare applications.

Platelet-derived growth factor (PDGF) is a protein released from blood platelets. It’s been proven to aid in the healing of wounds as a catalyst for tissue regeneration.

PDGF Deep Dive

PDGF-BB is a protein that drives cell growth, proliferation and extracellular matrix (ECM) deposition, critical for angiogenesis, bone formation, blood vessel repair and wound healing.

Platelet-derived growth factor (PDGF) aids wound healing as catalyst for tissue regeneration by gathering and activating cells through chemotaxis (cell migration).

The world’s leading authority on growth factors

Lynch Regenerative Medicine Founder and CEO, Samuel Lynch, DMSc, DMD, is an internationally recognized expert in regenerative medicine. He holds dual doctorates in Medical Sciences and Periodontal Medicine from Harvard University, where he began his journey as the leading clinical expert on PDGF.

Read Dr. Lynch's origin story

Dr. Lynch working in a laboratory with a variety of beakers and flasks

Decades of pioneering research

Explore a sampling of peer-reviewed papers and clinical trials on PDGF’s benefits, safety, and clinical evolution.

Expand your PDGF knowledge

The next generation of
skin rejuvenation

LRM Aesthetics was created in 2023 to introduce pure PDGF to the aesthetics market, a revolutionary, science-backed topical cosmetic for post-treatment use.

See the power of nature itself

Transforming
diabetic wound care

With the 2025 acquisition of Regranex® (becaplermin) gel 0.01%, which Dr. Lynch originally launched in 1997, he created LRM WoundCare to support the Brand’s relaunch to the broader market.

Wound care & skin regeneration

PDGF stimulates cell migration (chemotaxis), by acting as a powerful chemoattractant, guiding cells like fibroblasts and smooth muscle cells to the site of injury, promoting tissue regeneration and wound healing.

Bringing together science and nature for life-changing patient care

Lynch Regenerative Medicine is a leader and pioneer in regenerative biotherapeutics. Leveraging decades of experience in the research and clinical application of platelet-derived growth factor (PDGF), we are combining tomorrow’s science with nature’s most powerful healing protein to transform wound care and skin rejuvenation.

We are LRM